SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: Dan Spillane who wrote (1068)2/3/1999 2:13:00 PM
From: JGoren  Read Replies (2) | Respond to of 2539
 
Celebrex Prescriptions for Tuesday Exceed 14,500, NDC Health Information Services. NDC's DirectRx service tracks prescription sales at U.S. pharmacies. <Bloomberg reports>



To: Dan Spillane who wrote (1068)2/3/1999 3:07:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 2539
 
Dan, it's even better: 12% - 12.5% for PFE, 88% -87.5% for MTC. I guess the percentage (the cut) is tied to sales.

PFE share price continues to rise, not that I'm complaining, since I hold PFE as well.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News